Skip to main content
. Author manuscript; available in PMC: 2009 Nov 1.
Published in final edited form as: Cancer. 2008 Nov 1;113(9):2488–2495. doi: 10.1002/cncr.23854

Table 4.

Combined analysis for the number of unfavorable genotypes* in cell-cycle control pathways

Risk (No. of
unfavorable
genotypes)
No. of
controls
No. of
patients
OR (95% CI) P value
Low(1∼2) 37 5 Ref.
Medium (3) 56 39 5.01(1.74-14.40) 0.0028
High (4∼5) 39 43 6.18(2.14-17.86) 0.0008
P for the trend 0.002
*

Unfavorable genotypes: CCND1 P241P(AG/AA), P53 R72P (GG/GC), CDK4 3′UTR (AA/AC), P27 5′UTR (TT), CDK6 3′UTR(CC), STK15 F31I (AA),

Adjusted by age, gender, ethnicity, smoking status, and alcohol use

Abbreviations: CI = confidence interval; OR = odds ratio.